China CDC weekly · 2026
Global Burden of Disease Study on the Changing Landscape of Hematologic Malignancies and the Growing Impact of Elevated Body Mass Index - Asia, 1990-2023.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Yuan, Xu Ning, Guo Jingjing, Yang Yan, Yin Peng, Peng Zhihang, Chen Yang, Shi Hui, Gu Yan
Аннотация
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Hematologic malignancies constitute a growing health burden in Asia. Their long-term subregional patterns, future trajectories, and the contribution of high body mass index (BMI) have not been comprehensively evaluated within a unified framework.
WHAT IS ADDED BY THIS REPORT?: From 1990 to 2023, leukemia mortality declined across Asia, whereas non-Hodgkin lymphoma and multiple myeloma incidence and mortality increased in most subregions with multiple myeloma showing the fastest growth through 2040. Mendelian randomization suggested a potential association between BMI and malignant lymphoma in East Asian populations.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: Priorities include improving multiple myeloma detection and treatment access, strengthening care for aging populations, and integrating obesity prevention into cancer prevention programs.
WHAT IS ADDED BY THIS REPORT?: From 1990 to 2023, leukemia mortality declined across Asia, whereas non-Hodgkin lymphoma and multiple myeloma incidence and mortality increased in most subregions with multiple myeloma showing the fastest growth through 2040. Mendelian randomization suggested a potential association between BMI and malignant lymphoma in East Asian populations.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: Priorities include improving multiple myeloma detection and treatment access, strengthening care for aging populations, and integrating obesity prevention into cancer prevention programs.